Noev Alexey, Likhobabina Daria, Sutemieva Janna, Plyutinskaya Anna, Cheshkov Dmitry, Morozova Natalia, Vinokurova Aleksandra, Vasil'ev Yuriy, Suvorov Nikita, Nemtzova Elena, Pankratov Andrei, Filonenko Elena, Shegay Petr, Kaprin Andrey, Grin Mikhail
Department of Chemistry and Technology of Biologically Active Compounds, Medicinal and Organic Chemistry, Institute of Fine Chemical Technologies, MIREA-Russian Technological University, 86 Vernadsky Avenue, 119571 Moscow, Russia.
P. Hertsen Moscow Oncology Research Institute-Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, 2nd Botkinsky pr. 3, 125284 Moscow, Russia.
Int J Mol Sci. 2025 Mar 31;26(7):3244. doi: 10.3390/ijms26073244.
The insufficient selectivity of existing local anesthetics can lead to serious adverse effects. Considering the widespread use of this class of drugs, the development of new local anesthetics that do not cause side effects is an important task. One approach to address this issue is the use of photopharmacology, which enables the creation of agents with light-controlled biological activity. Several examples of azobenzene-based photoswitchable blockers of voltage-gated sodium (Na) channels have been described so far. These compounds can be used as light-controlled local anesthetics, one of which is ethercaine, synthesized by our group earlier. However, systematic studies of the "structure-activity" relationship in the series of light-controlled local anesthetics based on azobenzene are absent in the literature. The aim of this study was to obtain new derivatives of ethercaine and investigate their photophysical and biological properties. A total of 14 new derivatives were synthesized, and their structure was confirmed by various physicochemical analysis methods. The Z-E isomerization half-lifes were determined for all the synthesized compounds. The cytotoxic effect on normal cells was studied in vitro using human dermal fibroblasts (DF2). The local anesthetic activity of all the synthesized compounds was evaluated in vivo on a model of surface anesthesia in both darkness and under UV light irradiation. Based on the results obtained, conclusions were drawn regarding the potential of the proposed substances, and optimal pathways for structural modification were identified.
现有局部麻醉药的选择性不足会导致严重的不良反应。鉴于这类药物的广泛使用,开发无副作用的新型局部麻醉药是一项重要任务。解决这一问题的一种方法是使用光药理学,它能够创造出具有光控生物活性的药物。到目前为止,已经描述了几种基于偶氮苯的电压门控钠(Na)通道光开关阻滞剂的例子。这些化合物可用作光控局部麻醉药,其中之一是我们小组 earlier 合成的依替卡因。然而,文献中缺乏对基于偶氮苯的光控局部麻醉药系列中“构效”关系的系统研究。本研究的目的是获得依替卡因的新衍生物,并研究它们的光物理和生物学性质。总共合成了14种新衍生物,并通过各种物理化学分析方法确认了它们的结构。测定了所有合成化合物的Z-E异构化半衰期。使用人皮肤成纤维细胞(DF2)在体外研究了对正常细胞的细胞毒性作用。在黑暗和紫外线照射下,在表面麻醉模型上体内评估了所有合成化合物的局部麻醉活性。根据获得的结果,得出了关于所提出物质潜力的结论,并确定了结构修饰的最佳途径。